Depression

Zydus Lifesciences gets US health regulator's nod for its generic medicine

Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator for its generic doxepin hydrochloride capsules used in the treatment of depression and anxiety. The approval granted by the US Food and Drug Administration (USFDA) is for doxepin hydrochloride capsules of strength 150 mg, the company said in a regulatory filing. The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, it added. Doxepin hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety. It helps improve moods and feelings of well-being, relieves anxiety and tension, helps sleep better and increases the energy level, it added. The drug had annual sales of USD 2.11 million in the US, the company said citing IQVIA MAT January 2023 data.

Lupin gets approval for generic medicine for schizophrenia, depression

Pharmaceuticals firm Lupin Ltd on Tuesday said it has received approval from the US health regulator for its generic Brexpiprazole tablets used to treat the symptoms of schizophrenia and depression. The approval granted by the US Food and Drug Administration (US FDA) is for the abbreviated new drug application for Brexpiprazole tablets of strengths 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, the company said in a regulatory filing. These are generic equivalent of Rexulti tablets of Otsuka Pharmaceutical Company Ltd, it added. "This product would be manufactured at Lupin's Pithampur facility in India," the company said. Lupin said Brexpiprazole tablets 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, had an estimated annual sales of USD 1,575 million in the US, citing IQVIA MAT December 2022 data.

Long Covid cuts brain oxygen, worsens cognitive problems, depression

Long Covid is associated with reduced brain oxygen levels, worse performance on cognitive tests and increased psychiatric symptoms such as depression and anxiety, according to new research

Zydus gets USFDA nod to market generic medicine for treating depression

Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) in adults

Physical activity may help reduce depression in youngsters, finds study

Scientists have found that physical activity interventions were associated with significant reductions in depressive symptoms in children and adolescents. The available evidence supported physical activity interventions as an alternative or adjunctive approach to alleviate depressive symptoms in children and adolescents, substantiating the beneficial influence of physical activity on the mental health of pediatric populations. This systematic review and meta-analysis included 21 studies involving 2441 participants. Depression is the second most prevalent mental disorder among children and adolescents, with an estimated prevalence rate of 6.2 per cent globally, yet only a small proportion seek or receive disorder-specific treatment. Early childhood depression is associated with severe adverse outcomes, including difficulties with social functioning, poor mental and physical health, and suicide. The incidence of depressive symptoms at a young age is a strong predictor of future menta

Yoga, Zumba, mental wellness in focus as student suicides shake Kota

From Yoga sessions and Zumba classes to 24X7 helpline, and mental wellness workshops to a dedicated team of counsellors on campus -- coaching institutes in Kota say they take multiple measures to help students get through the stress and anxiety of preparing for competitive exams. The coaching hub of Kota is back in focus after three students died allegedly by suicide last week. Prominent coaching institute Allen, which currently has over 1.5 lakh students in its various medical (NEET) and engineering (JEE) entrance preparatory courses, runs special programmes such as "Tum Hoge Kamyab" (you will succeed) and "Wings of Wisdom", besides regular yoga sessions and zumba classes, for the mental wellbeing of its students. "We have a dedicated helpline which works round the clock and over 50 concerned calls from students or parents are addressed daily through it," said Dr Harish Sharma, Principal Counsellor and Student-Behaviour Expert at Allen. "For every 10 students we have a supervising

India lacks adequate community level data for hypertension control: Lancet

More than 50 per cent of patients in India are unaware of their high blood pressure, finds a study published in Lancet Regional Health Journal

77% employees think work-related stress induces anxiety, depression: Report

Work-related stress leads to adverse effects on employees' mental health and reduces work efficiency, with 77 per cent respondents saying stress can induce anxiety and depression, according to a report. While 77 per cent of the participants in the survey confirmed that work-related stress can induce anxiety and depression, 14 per cent were neutral and a meagre 9 per cent denied the possibility altogether, according to HR solutions provider Genius Consultants' report. The report is based on a survey among 1,380 employees from September 5 till October 15, 2022, across sectors like banking and finance, construction and engineering, education, FMCG, hospitality, HR solutions, IT, ITES and BPO, logistics and manufacturing. The report further revealed that 82 per cent of the participants validated that health issues like immunodeficiency disorders, gastrointestinal disorders and musculoskeletal disorders are directly connected with work-related stress, while 14 per cent remained neutral a

Facebook announces 2022 Community Accelerator participants in India

Four-month programme provides selected community leaders of Facebook groups with training, mentorship and funding

Buy an adequate OPD cover to take care of mental health treatment

Most of these ailments are treated on outpatient basis, so just a hospitalisation cover won't suffice

Nearly one in 10 in US report having depression, reveals new study

Around one in 10 people in the US reported to have depression, the leading cause of disability around the world, in 2020, claims a new study

Deep depression weakens over northwest Chhattisgarh; rain continues: IMD

The India Meteorological Department (IMD) on Sunday informed that a deep depression over northwest Chhattisgarh, adjoining Madhya Pradesh and southeast Uttar Pradesh has weakened into a depression.The IMD said that the depression will continue to move west-northwestwards across north Madhya Pradesh and weaken into a well-marked low-pressure area during the next 24 hours."Deep Depression over Northwest Chhattisgarh and adjoining Northeast Madhya Pradesh & Southeast Uttar Pradesh weakened into a Depression and lay centered at 0530 hrs IST of today over the same region about 120 km west-northwest of Ambikapur (Chhattisgarh), 150 km southwest of Churk (Uttar Pradesh), 170 km east-southeast of Satna and 120 km east of Umaria (Madhya Pradesh). It would continue to move west-northwestwards across north Madhya Pradesh and weaken into a Well Marked Low-Pressure Area during next 24 hours," tweeted IMD.The IMD further predicted that Rainfall at most places with heavy to very heavy rainfall

All in the mind: Yoga and meditation courses to bust stress and depression

There is a universe of institutions and mental wellness experts to help you beat Covid-induced doldrums and get your life back on track

US Senate passes bill to make daylight saving time permanent, starting 2023

The US Senate on Tuesday passed legislation that would make Daylight Saving Time permanent, consequently ending time switches in the springtime and autumn should the House pass their own version

Long Covid-induced diabetes, depression can be treated by exercise: Study

Though no medically recognized treatment exists for Long Covid, a study suggests that exercise might break cycle of inflammation that develops diabetes and depression months after a person recovers

WHO warns of sharp rise in Covid-induced anxiety, depression worldwide

WHO warned on Wednesday of a sharp increase in the prevalence of anxiety and depression related to the Covid-19 pandemic, caused largely by social isolation, young people and women are the worst hit

14 killed in Tamil Nadu, depression crosses coast near Chennai

In Chennai, flooding transformed several areas into a virtual large water body

Zydus Cadila gets USFDA nod to market depression treatment drug in US

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Vortioxetine Tablets, used to treat depression, in the American market.

Rise in anxiety, depression cases during second wave of Covid-19: Experts

The study conducted by a private hospital in Delhi has found that there has been a rise in anxiety and depression cases among the people during the second wave of Covid-19 in April-May

Covid doubled depression, anxiety symptoms in children, youth: Study

Depression and anxiety symptoms have doubled in children and adolescents when compared to pre-pandemic times, according to an alarming study